Simi Valley, CA, United States of America

Rafi Muhammad Sufi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rafi Muhammad Sufi: Innovator in Drug Delivery Systems

Introduction

Rafi Muhammad Sufi is an accomplished inventor based in Simi Valley, CA. He has made significant contributions to the field of drug delivery systems, showcasing his innovative spirit and dedication to improving healthcare solutions.

Latest Patents

Rafi holds a patent for a take-home drug delivery system. This system includes a kit container that defines an inner volume, a drug delivery container preparation assembly, and a sterile drape. The drug delivery container preparation assembly consists of a drug delivery container, a drug vial containing the drug to be administered, a tubing set, and a drug delivery container mounting apparatus. The sterile drape features a placement legend illustrated thereon, enhancing its usability.

Career Highlights

Rafi Muhammad Sufi has been instrumental in advancing drug delivery technologies. His work at Amgen Inc. has allowed him to collaborate with leading professionals in the industry, furthering the development of innovative healthcare solutions.

Collaborations

Some of Rafi's notable coworkers include Adam B McCullough and Sarah M Korman. Their collective expertise contributes to the success of their projects and the advancement of drug delivery systems.

Conclusion

Rafi Muhammad Sufi is a notable inventor whose work in drug delivery systems exemplifies innovation in healthcare. His contributions are paving the way for more effective and accessible treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…